132 related articles for article (PubMed ID: 34492570)
1. Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers.
Ziegler GC; Radtke F; Vitale MR; Preuße A; Klopocki E; Herms S; Lesch KP
Stem Cell Res; 2021 Oct; 56():102526. PubMed ID: 34492570
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3.
Jansch C; Günther K; Waider J; Ziegler GC; Forero A; Kollert S; Svirin E; Pühringer D; Kwok CK; Ullmann R; Maierhofer A; Flunkert J; Haaf T; Edenhofer F; Lesch KP
Stem Cell Res; 2018 Apr; 28():136-140. PubMed ID: 29477591
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
4. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
5. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population.
Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP
Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
[TBL] [Abstract][Full Text] [Related]
8. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol.
Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X
Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158
[TBL] [Abstract][Full Text] [Related]
10. Cellular effects and clinical implications of SLC2A3 copy number variation.
Ziegler GC; Almos P; McNeill RV; Jansch C; Lesch KP
J Cell Physiol; 2020 Dec; 235(12):9021-9036. PubMed ID: 32372501
[TBL] [Abstract][Full Text] [Related]
11. Generation of two human induced pluripotent stem cell lines derived from myoblasts (MDCi014-A) and from peripheral blood mononuclear cells (MDCi014-B) from the same donor.
Metzler E; Telugu N; Diecke S; Spuler S; Escobar H
Stem Cell Res; 2020 Oct; 48():101998. PubMed ID: 32979629
[TBL] [Abstract][Full Text] [Related]
12. Generation of the induced pluripotent stem cell line UHOMi002-A from peripheral blood mononuclear cells of a healthy male donor.
Fieldes M; Ahmed E; Bourguignon C; Mianné J; Martin M; Arnould C; Vachier I; Assou S; De Vos J; Bourdin A
Stem Cell Res; 2020 Dec; 49():102037. PubMed ID: 33099111
[TBL] [Abstract][Full Text] [Related]
13. Generation of four iPSC lines from Neurofibromatosis Type 1 patients.
Bozaoglu K; Shern Lee W; Haebich KM; North KN; Payne JM; Lockhart PJ
Stem Cell Res; 2020 Dec; 49():102013. PubMed ID: 33091851
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
16. SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder.
Merker S; Reif A; Ziegler GC; Weber H; Mayer U; Ehlis AC; Conzelmann A; Johansson S; Müller-Reible C; Nanda I; Haaf T; Ullmann R; Romanos M; Fallgatter AJ; Pauli P; Strekalova T; Jansch C; Vasquez AA; Haavik J; Ribasés M; Ramos-Quiroga JA; Buitelaar JK; Franke B; Lesch KP
J Child Psychol Psychiatry; 2017 Jul; 58(7):798-809. PubMed ID: 28224622
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line (FMCPGHi001-A) from a 25-year-old Chinese Han healthy male donor.
Wang T; Tang W; Zeng Q; Miao S; Pi C; Li Y; Yue W; Yu S
Stem Cell Res; 2022 Apr; 60():102735. PubMed ID: 35247846
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male.
Wu H; Cheng Y; Lv Z; Liu L; Gong W; Zhang S
Stem Cell Res; 2021 May; 53():102221. PubMed ID: 33677395
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
20. Generation of three human iPSC lines from patients with a spontaneous late-onset Alzheimer's disease and three sex- and age-matched healthy controls.
Raska J; Klimova H; Sheardova K; Fedorova V; Hribkova H; Pospisilova V; Vochyanova S; Vanova T; Bohaciakova D
Stem Cell Res; 2021 May; 53():102378. PubMed ID: 34088007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
